Is Alphagan in shortage in 2026? Get the latest update on Brimonidine eye drop availability, why it's hard to find, pricing, and how to locate it in stock.
If you've had trouble filling your Alphagan (Brimonidine tartrate) prescription recently, you're probably wondering whether there's an official shortage — and when things will get back to normal.
Let's cut through the confusion and give you a clear, honest picture of where things stand in 2026.
As of early 2026, Alphagan and generic Brimonidine ophthalmic solution are not listed on the FDA's official drug shortage database. That's good news — it means there isn't a nationwide, systemic supply failure.
However, that doesn't mean every pharmacy has it on the shelf every day. Many patients are still experiencing intermittent stock-outs at their local pharmacies. This disconnect between "no official shortage" and "I can't find my drops" is frustrating, but it's a common pattern with ophthalmic medications.
There's a difference between a supply shortage and a distribution gap. Here's what's driving the problem:
Pharmacies manage inventory tightly to avoid waste. Eye drops like Alphagan have a relatively small patient base compared to blockbuster medications, so pharmacies may not keep deep stock. When a few extra prescriptions come in at once, the shelf empties quickly.
While multiple manufacturers produce generic Brimonidine, individual companies occasionally experience production delays. If the manufacturer your pharmacy's distributor prefers has a temporary hiccup, it can take days or weeks for an alternative supply to fill the gap.
Some insurance plans have strict formulary requirements that direct patients to specific formulations (0.1% vs. 0.15% vs. 0.2%) or specific manufacturers. If that particular version isn't available, patients are stuck — even when other versions of the same drug are sitting on the shelf.
Glaucoma diagnoses and follow-ups often spike after eye exams, which tend to cluster at certain times of year. This can create temporary demand surges that outpace local supply.
Cost is a real factor in availability — if you can't afford the brand, and the generic at your preferred pharmacy is out, you might feel stuck. Here's the current pricing landscape:
The generic is significantly more affordable and widely available. If you've been paying full price for brand Alphagan P, switching to the generic could save you $100 or more per bottle. Check out our complete guide to saving money on Alphagan for coupon details and patient assistance programs.
The glaucoma treatment landscape continues to evolve:
If you're curious about alternatives, our guide to Alphagan alternatives covers the most common options in detail.
If you need Alphagan today, here are your best moves:
For a deeper dive into these strategies, read our guide on how to find Alphagan in stock near you.
The Alphagan situation in 2026 isn't a crisis — but it's not seamless either. The drug is being manufactured, generics are available, and most patients can find it with a little effort. The key is being proactive: refill early, use tools like Medfinder, and keep your eye doctor in the loop.
Glaucoma is a condition where consistent treatment makes all the difference between preserving your sight and losing it. Don't let a temporary stock-out become a treatment gap. Use the resources available to you, and don't hesitate to reach out to your healthcare team if you're struggling.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
